Respiratory syncytial virus (RSV) vaccination is recommended in pregnancy. Limited data exist regarding antibody (Ab) durability to inform revaccination timing. They conducted prospective cohort studies among pregnant and older adults after first RSV vaccination in 2023–2024.
